These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15123855)

  • 1. Citalopram and quality of life in lung transplant recipients.
    Silvertooth EJ; Doraiswamy PM; Clary GL; Babyak MA; Wilkerson N; Hellegars C; Palmer SM
    Psychosomatics; 2004; 45(3):271-2. PubMed ID: 15123855
    [No Abstract]   [Full Text] [Related]  

  • 2. Variations in response to citalopram in men and women with alcohol dependence.
    Naranjo CA; Knoke DM; Bremner KE
    J Psychiatry Neurosci; 2000 May; 25(3):269-75. PubMed ID: 10863887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Psychopharmacological approach with the usage of selective serotonin reuptake inhibitors in functional dyspepsia treatment].
    Korendovych IV; Svintsits'kyĭ AS; Revenok KM; Maliarov SO
    Lik Sprava; 2014 Nov; (11):58-64. PubMed ID: 25528834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A new quality of the therapy of anxiety and depression--escitalopram].
    Neznanov NG; Bortsov AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(2):79-84. PubMed ID: 15792148
    [No Abstract]   [Full Text] [Related]  

  • 5. Citalopram versus other selective serotonin-reuptake inhibitors.
    Thomas KV; Holimon TD
    Am J Health Syst Pharm; 1999 Nov; 56(21):2242-4. PubMed ID: 10565706
    [No Abstract]   [Full Text] [Related]  

  • 6. May depressed and anxious patients with carcinoid syndrome benefit from treatment with selective serotonin reuptake inhibitors (SSRIs)?: findings from a case report.
    Nobels A; Geboes K; Lemmens GM
    Acta Oncol; 2016 Nov; 55(11):1370-1372. PubMed ID: 27169982
    [No Abstract]   [Full Text] [Related]  

  • 7. Escitalopram-Induced Rash.
    Prabhakar D; Sablaban I
    Prim Care Companion CNS Disord; 2019 Jan; 21(1):. PubMed ID: 30806996
    [No Abstract]   [Full Text] [Related]  

  • 8. A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome.
    Tack J; Broekaert D; Fischler B; Van Oudenhove L; Gevers AM; Janssens J
    Gut; 2006 Aug; 55(8):1095-103. PubMed ID: 16401691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression after lung transplantation: causes and treatment.
    Fusar-Poli P; Lazzaretti M; Ceruti M; Hobson R; Petrouska K; Cortesi M; Pozzi E; Politi P
    Lung; 2007; 185(2):55-65. PubMed ID: 17393235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin transporter 5-HTTLPR polymorphism and response to citalopram in terminally ill cancer patients: report of twenty-one cases.
    Capozzo MA; Schillani G; Aguglia E; De Vanna M; Grassi L; Conte MA; Giraldi T
    Tumori; 2009; 95(4):479-83. PubMed ID: 19856660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Citalopram in Treating Post-Stroke Depression: A Meta-Analysis.
    Tan S; Huang X; Ding L; Hong H
    Eur Neurol; 2015; 74(3-4):188-201. PubMed ID: 26559658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citalopram for depression.
    Med Lett Drugs Ther; 1998 Dec; 40(1041):113-4. PubMed ID: 9854566
    [No Abstract]   [Full Text] [Related]  

  • 13. Citalopram plus reboxetine in treatment-resistant depression.
    Devarajan S; Dursun SM
    Can J Psychiatry; 2000 Jun; 45(5):489-90. PubMed ID: 10900531
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective serotonin re-uptake inhibitors (SSRIs) and alopecia areata.
    Ruiz-Doblado S; Carrizosa A; García-Hernández MJ; Rodríguez-Pichardo A
    Int J Dermatol; 1999 Oct; 38(10):798-9. PubMed ID: 10561061
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective serotonin re-uptake inhibitors beyond psychiatry: are they useful in the treatment of severe, chronic, obstructive pulmonary disease?
    Perna G; Cogo R; Bellodi L
    Depress Anxiety; 2004; 20(4):203-4. PubMed ID: 15643645
    [No Abstract]   [Full Text] [Related]  

  • 16. Interaction potential of selective serotonin-reuptake inhibitors.
    DeVane CL
    Am J Health Syst Pharm; 2000 Oct; 57(19):1802-3. PubMed ID: 11030037
    [No Abstract]   [Full Text] [Related]  

  • 17. Rat behavior after chronic variable stress and partial lesioning of 5-HT-ergic neurotransmission: effects of citalopram.
    Tõnissaar M; Mällo T; Eller M; Häidkind R; Kõiv K; Harro J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):164-77. PubMed ID: 17826880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anxiodepressive and neuromediatory disorders in hypertensive patients. Effects of cypramil therapy].
    Nedostup AV; Fedorova VI; Linevich AIu; Pukhal'skaia TG; Toropina GG; Kudrin VS; Klodt PM
    Ter Arkh; 2005; 77(11):55-62. PubMed ID: 16404864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug treatment of psychological alterations in inflammatory bowel disease: application by the gastroenterologist].
    Bedmar Noguerol M
    Gastroenterol Hepatol; 2009 Oct; 32 Suppl 2():19-24. PubMed ID: 19900624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Citalopram as an adjuvant in schizophrenia: further evidence for a serotonergic dimension in schizophrenia.
    Taiminen TJ; Syvälahti E; Saarijärvi S; Niemi H; Lehto H; Ahola V; Salokangas RK
    Int Clin Psychopharmacol; 1997 Jan; 12(1):31-5. PubMed ID: 9179631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.